glp 1 receptor agonist agent GLP-1 Agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonists show promise
Description
The Revolutionary Role of GLP-1 Agonists and SGLT-2 Inhibitors in Managing Diabetes and Chronic Kidney Disease Shankar Chakkera, Elizabeth J
Unlike GLP-1, GIP has little acute ...
Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)
In addition, this report is a consensus of expert endocrinologists representing South Asian countries including India, Pakistan, Bangladesh, Nepal, Sri Lanka, Afghanistan and the Maldives on essential recommendations related to the use of GLP-1 RAs in a real-world scenario.
Powered by Peptide
Startin...
